Page last updated: 2024-08-25

lead and Hyperparathyroidism, Secondary

lead has been researched along with Hyperparathyroidism, Secondary in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (16.67)	18.7374
1990's	2 (33.33)	18.2507
2000's	1 (16.67)	29.6817
2010's	2 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, CC; Chu, P; Lu, KC; Ma, WY; Wu, CC; Wu, HC	1
Chen, CC; Chu, P; Lu, KC; Wu, CC	1
Batuman, V; Ghosh-Narang, J; Jones, TM; Menke, A; Muntner, P; Todd, AC	1
Chanliau, J; Duc, M; Durand, PY; Huu, TC; Kessler, M; Netter, P; Royer-Morot, MJ	1
Hügel, U; Mall, G; Merke, J; Ritz, E; Stoeppler, M; Szabo, A	1
Au, WY; Raisz, LG	1

Reviews

1 review(s) available for lead and Hyperparathyroidism, Secondary

Article	Year
Drugs toxic to bone. Seminars in drug treatment, 1972,Summer, Volume: 2, Issue:1 Topics: Adrenal Cortex Hormones; Antacids; Antibiotics, Antineoplastic; Anticoagulants; Anticonvulsants; Bone and Bones; Bone Diseases; Cadmium; Cathartics; Chronic Disease; Dactinomycin; Diuretics; Drug-Related Side Effects and Adverse Reactions; Fluorides; Humans; Hyperparathyroidism, Secondary; Iron; Lead; Methotrexate; Plicamycin; Radium; Tetracycline; Vitamin A; Vitamin D	1972

Article

Year

Drugs toxic to bone.

Seminars in drug treatment, 1972,Summer, Volume: 2, Issue:1

Topics: Adrenal Cortex Hormones; Antacids; Antibiotics, Antineoplastic; Anticoagulants; Anticonvulsants; Bone and Bones; Bone Diseases; Cadmium; Cathartics; Chronic Disease; Dactinomycin; Diuretics; Drug-Related Side Effects and Adverse Reactions; Fluorides; Humans; Hyperparathyroidism, Secondary; Iron; Lead; Methotrexate; Plicamycin; Radium; Tetracycline; Vitamin A; Vitamin D

1972

Trials

1 trial(s) available for lead and Hyperparathyroidism, Secondary

Article	Year
Decreased blood lead levels after calcitriol treatment in hemodialysis patients with secondary hyperparathyroidism. Bone, 2011, Volume: 49, Issue:6 Topics: Acid Phosphatase; Biomarkers; Bone and Bones; Calcitriol; Female; Humans; Hyperparathyroidism, Secondary; Isoenzymes; Lead; Male; Middle Aged; Parathyroid Hormone; Renal Dialysis; Tartrate-Resistant Acid Phosphatase	2011

Other Studies

4 other study(ies) available for lead and Hyperparathyroidism, Secondary

Article	Year
Parathyroidectomy leads to decreased blood lead levels in patients with refractory secondary hyperparathyroidism. Bone, 2012, Volume: 50, Issue:5 Topics: Acid Phosphatase; Biomarkers; Bone Remodeling; Calcium; Case-Control Studies; Female; Humans; Hyperparathyroidism, Secondary; Interleukin-6; Isoenzymes; Lead; Male; Middle Aged; Parathyroid Hormone; Parathyroidectomy; Renal Dialysis; Tartrate-Resistant Acid Phosphatase	2012
Parathyroid hormone status does not influence blood and bone lead levels in dialysis patients. The American journal of the medical sciences, 2007, Volume: 334, Issue:6 Topics: Adult; Black or African American; Bone and Bones; Bone Remodeling; Calcium; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Lead; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis; Serum Albumin; Sex Factors; Tibia	2007
Mobilization of lead from bone in end-stage renal failure patients with secondary hyperparathyroidism. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1999, Volume: 14, Issue:11 Topics: Aged; Biological Transport; Bone and Bones; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Lead; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Renal Dialysis	1999
Hyperparathyroidism and abnormal 1,25(OH)2 vitamin D3 metabolism in experimental lead intoxication. European journal of clinical investigation, 1991, Volume: 21, Issue:5 Topics: Animals; Calcitriol; Hyperparathyroidism, Secondary; Hypocalcemia; Lead; Male; Rats; Rats, Inbred WKY; Receptors, Calcitriol; Receptors, Steroid; Time Factors	1991